Brief: Prostatype Genomics Announces Strong Results For Prostatype In First Step Validation Study Of Asian Population
March 31 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE GENOMICS ANNOUNCES STRONG RESULTS FOR
PROSTATYPE® IN
FIRST STEP VALIDATION STUDY OF ASIAN POPULATION
* RESULTS IN LINE WITH WHAT WE HAVE SEEN IN EXTERNAL
VALIDATION
STUDIES PERFORMED IN EUROPE, MEANING THAT APPROXIMATELY 1/3 OF
PATIENTS ARE RECLASSIFIED BY USING PROSTATYPE® TECHNOLOGY
Source text for Eikon: ID:nWkr1797Dk
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants